These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6939477)

  • 1. Chemoimmunotherapy of adult acute leukemia.
    McCredie KB; Bodey GP; Freireich EJ; Hester JP; Rodriguez V; Keating MJ
    Cancer; 1981 Mar; 47(6):1256-61. PubMed ID: 6939477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapy.
    Bodey GP; Freireich EJ; McCredie KB; Smith TL; Gehan EA; Gutterman JU; Hersh EM
    Cancer; 1981 Apr; 47(8):1937-45. PubMed ID: 6939480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of 100 acute myeloid leukemias (author's transl)].
    Fière D; Martin C; Vu Van H; Coiffier B; Felman P; Bryon PA; Favre-Gilly J; Revol L
    Sem Hop; 1979 Apr 8-15; 55(13-14):633-8. PubMed ID: 224478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoimmunotherapy with Corynebacterium parvum in acute myelocytic leukemia.
    Eppinger-Helft M; Pavlovsky S; Hidalgo G; Muriel FS; Suárez A; Garay G; Russo C; Santos M; Macchi A; Lein J
    Cancer; 1980 Jan; 45(2):280-4. PubMed ID: 6985835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute myelogenous leukemia: influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy.
    Omura GA; Vogler WR; Lefante J; Silberman H; Knospe W; Gordon D; Jarrell R
    Cancer; 1982 Apr; 49(8):1530-6. PubMed ID: 7039813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy and immunotherapy for acute myelogenous leukemia.
    Lister TA; Whitehouse JM; Oliver RT; Bell R; Johnson SA; Wrigley PF; Ford JM; Cullen MH; Gregory W; Paxton AM; Malpas JS
    Cancer; 1980 Nov; 46(10):2142-8. PubMed ID: 6932992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccine.
    Hewlett JS; Chen T; Balcerzak SP; Gutterman JU; Costanzi JJ; Amare M
    Arch Intern Med; 1985 Jun; 145(6):1006-12. PubMed ID: 3890786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
    Presant CA; Berger NA; Klahr C; Phillips GL
    Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late intensification therapy for acute leukemia in remission. Chemotherapy and immunotherapy.
    Bodey GP; Freireich EJ; Gehan E; McCredie KB; Rodriguez V; Gutterman J; Burgess MA
    JAMA; 1976 Mar; 235(10):1021-5. PubMed ID: 946184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensification therapy for acute nonlymphoblastic leukemia in adults.
    Glucksberg H; Cheever MA; Farewell VT; Fefer A; Thomas ED
    Cancer; 1983 Jul; 52(2):198-205. PubMed ID: 6344977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenance.
    Morrison FS; Kopecky KJ; Head DR; Athens JW; Balcerzak SP; Gumbart C; Dabich L; Costanzi JJ; Coltman CA; Saiki JH
    Leukemia; 1992 Jul; 6(7):708-14. PubMed ID: 1625490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLL.
    Baehner RL; Bernstein ID; Sather H; Higgins G; McCreadie S; Chard RL; Hammond D
    Med Pediatr Oncol; 1979; 7(2):127-39. PubMed ID: 291771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature of remission in acute myeloblastic leukaemia.
    Powles RL; Selby PJ; Palu G; Morgenstern G; McElwain TJ; Clink HM; Alexander P
    Lancet; 1979 Sep; 2(8144):674-6. PubMed ID: 90762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia.
    Sackmann-Muriel F; Svarch E; Eppinger-Helft M; Braier JL; Pavlovsky S; Guman L; Vergara B; Ponzinibbio C; Failace R; Garay GE; Bugnard E; Ojeda FG; De Bellis R; de Sijvarger SR; Saslavsky J
    Cancer; 1978 Oct; 42(4):1730-40. PubMed ID: 101296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia.
    Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Bodey GP; Freireich EJ
    Cancer; 1986 Oct; 58(8):1603-8. PubMed ID: 3463390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemia.
    Peterson BA; Bloomfield CD; Bosl GJ; Gibbs G; Malloy M
    Cancer; 1980 Aug; 46(4):663-8. PubMed ID: 7397631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of adult acute leukemia. A Southwest Oncology Group study.
    McCredie KB; Gehan EA; Freireich EJ; Hewlett JS; Coltman CA; Hussein KK; Balcerzak SP; Chen TT
    Cancer; 1983 Sep; 52(6):958-66. PubMed ID: 6883280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of adult acute myelogenous leukaemia.
    Crowther D; Powles RL; Bateman CJ; Beard ME; Gauci CL; Wrigley PF; Malpas JS; Fairley GH; Scott RB
    Br Med J; 1973 Jan; 1(5846):131-7. PubMed ID: 4513355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifying the biological response to acute myeloid leukemia I. BCG, allogeneic leukemic cells and spontaneous cytotoxicity.
    Arends-Merino A; Sjögren AM; Reizenstein P
    Anticancer Res; 1983; 3(4):239-41. PubMed ID: 6576728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.